Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells

Background/Aim: MEK-ERK pathway plays major roles in the progression of thyroid cancer, while the use of MEK-ERK inhibitors has been limited by its toxicity. We investigated the effect of sodium selenite as an adjunct for MEK-ERK inhibitors to avoid the toxicity of ERK inhibitors. Materials and Methods: TPC1, 8505C and HTori-3 cells were treated with U0126 (MEK-ERK inhibitor) and cell viability was counted in the Neubauer chamber. The synergistic effects of sodium selenite and U0126 were also measured. The expression of ERK, p-ERK, and p90RSK was determined by western blot. Results: Treatment with U0126 inhibited proliferation of TPC1 and 8505C cells in a dose-dependent manner. When 5 μM sodium selenite was added to 1 μM U0126, relative cell survival further decreased. Decreased expression of p90RSK indicated that sodium selenite down-regulated ERK signaling in thyroid cancer cells. Conclusion: The combination of U0126 and sodium selenite inhibited proliferation of thyroid cancer cells through ERK inhibition.

[1]  A. Kipp.  Selenium in colorectal and differentiated thyroid cancer , 2019, Hormones.

[2]  P. Crespo,et al.  Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer. , 2019, Endocrine-related cancer.

[3]  X. Fang,et al.  Does dietary intake of selenium protect against cancer? A systematic review and meta-analysis of population-based prospective studies , 2020, Critical reviews in food science and nutrition.

[4]  Yan-Ming Xu,et al.  Selenium Species: Current Status and Potentials in Cancer Prevention and Therapy , 2018, International journal of molecular sciences.

[5]  C. Georgescu,et al.  Selenoproteins in human body: focus on thyroid pathophysiology , 2018, Hormones.

[6]  Kyu-Won Jung,et al.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015 , 2018, Cancer research and treatment : official journal of Korean Cancer Association.

[7]  A. De Luca,et al.  A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery , 2018, Cancer Cell International.

[8]  M. Kieliszek,et al.  Application of Sodium Selenite in the Prevention and Treatment of Cancers , 2017, Cells.

[9]  P. Macchia,et al.  Selenium supplementation modulates apoptotic processes in thyroid follicular cells , 2017, BioFactors.

[10]  B. Lipinski.  Sodium Selenite as an Anticancer Agent. , 2017, Anti-cancer agents in medicinal chemistry.

[11]  R. Ciampi,et al.  Targeted Therapy in Thyroid Cancer: State of the Art. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

[12]  L. Hegedüs,et al.  Selenium Supplementation Significantly Reduces Thyroid Autoantibody Levels in Patients with Chronic Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis. , 2016, Thyroid : official journal of the American Thyroid Association.

[13]  V. Seshan,et al.  Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine. , 2016, The Journal of clinical investigation.

[14]  Li Li,et al.  Sodium Selenite Inhibits Proliferation of Gastric Cancer Cells by Inducing SBP1 Expression. , 2016, The Tohoku journal of experimental medicine.

[15]  Xing Tan,et al.  Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma , 2016, World Journal of Surgical Oncology.

[16]  F. Aksoy,et al.  Changes in the Serum Levels of Trace Elements Before and After the Operation in Thyroid Cancer Patients , 2016, Biological Trace Element Research.

[17]  P. Kopp,et al.  Targeted therapies in advanced differentiated thyroid cancer. , 2015, Cancer treatment reviews.

[18]  Jie Cao,et al.  The Association Between Serum Levels of Selenium, Copper, and Magnesium with Thyroid Cancer: a Meta-analysis , 2015, Biological Trace Element Research.

[19]  L. Duntas,et al.  Selenium: an element for life , 2015, Endocrine.

[20]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[21]  J. Jonklaas,et al.  A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. , 2013, Thyroid : official journal of the American Thyroid Association.

[22]  Z. Li,et al.  Sodium selenite induces apoptosis in colon cancer cells via Bax-dependent mitochondrial pathway. , 2013, European review for medical and pharmacological sciences.

[23]  Ø. Bruserud,et al.  PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells , 2013, Cell Death and Disease.

[24]  Yang Yang,et al.  Sodium selenite alters microtubule assembly and induces apoptosis in vitro and in vivo , 2013, Journal of Hematology & Oncology.

[25]  Kaixun Huang,et al.  Selenium Protects Bone Marrow Stromal Cells Against Hydrogen Peroxide-Induced Inhibition of Osteoblastic Differentiation by Suppressing Oxidative Stress and ERK Signaling Pathway , 2012, Biological Trace Element Research.

[26]  Kaixun Huang,et al.  Selenium suppressed hydrogen peroxide‐induced vascular smooth muscle cells calcification through inhibiting oxidative stress and ERK activation , 2010, Journal of cellular biochemistry.

[27]  T. Fahey,et al.  Selenium Decreases Thyroid Cancer Cell Growth by Increasing Expression of GADD153 and GADD34 , 2009, Nutrition and cancer.

[28]  G. Clayman,et al.  Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors. , 2007, Archives of otolaryngology--head & neck surgery.

[29]  Yang Yang,et al.  Requirement for ERK activity in sodium selenite-induced apoptosis of acute promyelocytic leukemia-derived NB4 cells. , 2007, Journal of biochemistry and molecular biology.